CT‐based deep multi‐label learning prediction model for outcome in patients with oropharyngeal squamous cell carcinoma

Author:

Ma Baoqiang1,Guo Jiapan123,Zhai Tian‐Tian4,van der Schaaf Arjen1,Steenbakkers Roel J. H. M.1,van Dijk Lisanne V.15,Both Stefan1,Langendijk Johannes A.1,Zhang Weichuan6,Qiu Bingjiang12,van Ooijen Peter M. A.12,Sijtsema Nanna M.1

Affiliation:

1. Department of Radiation Oncology University of Groningen, University Medical Centre Groningen Groningen the Netherlands

2. Machine Learning Lab, Data Science Centre in Health (DASH), University of Groningen, University Medical Centre Groningen Groningen the Netherlands

3. Bernoulli Institute for Mathematics Computer Science and Artificial Intelligence, University of Groningen Groningen the Netherlands

4. Department of Radiation Oncology Cancer Hospital of Shantou University Medical College Shantou China

5. Department of Radiation Oncology The University of Texas MD Anderson Cancer Centre Houston Texas USA

6. Institute for Integrated and Intelligent Systems, Griffith University Queensland Australia

Abstract

AbstractBackgroundPersonalized treatment is increasingly required for oropharyngeal squamous cell carcinoma (OPSCC) patients due to emerging new cancer subtypes and treatment options. Outcome prediction model can help identify low or high‐risk patients who may be suitable to receive de‐escalation or intensified treatment approaches.PurposeTo develop a deep learning (DL)‐based model for predicting multiple and associated efficacy endpoints in OPSCC patients based on computed tomography (CT).MethodsTwo patient cohorts were used in this study: a development cohort consisting of 524 OPSCC patients (70% for training and 30% for independent testing) and an external test cohort of 396 patients. Pre‐treatment CT‐scans with the gross primary tumor volume contours (GTVt) and clinical parameters were available to predict endpoints, including 2‐year local control (LC), regional control (RC), locoregional control (LRC), distant metastasis‐free survival (DMFS), disease‐specific survival (DSS), overall survival (OS), and disease‐free survival (DFS). We proposed DL outcome prediction models with the multi‐label learning (MLL) strategy that integrates the associations of different endpoints based on clinical factors and CT‐scans.ResultsThe multi‐label learning models outperformed the models that were developed based on a single endpoint for all endpoints especially with high AUCs ≥ 0.80 for 2‐year RC, DMFS, DSS, OS, and DFS in the internal independent test set and for all endpoints except 2‐year LRC in the external test set. Furthermore, with the models developed, patients could be stratified into high and low‐risk groups that were significantly different for all endpoints in the internal test set and for all endpoints except DMFS in the external test set.ConclusionMLL models demonstrated better discriminative ability for all 2‐year efficacy endpoints than single outcome models in the internal test and for all endpoints except LRC in the external set.

Funder

China Scholarship Council

Rijksuniversiteit Groningen

Publisher

Wiley

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3